If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...

FDA-authorized alternatives to brand-name weight loss medications gain traction, offering cheaper options for patients.

Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions ...

A strange chase in Joinville in Brazil: police stopped a man riding in his wheelchair who was traveling fast on a country ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related ...

TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making compounded versions of the weight-loss medication ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

"Early weight loss may be a signal that you can be successful with lifestyle alone," Donald Hensrud, MD, MS, medical editor ...

The former immigration minister, who lost four stone in 12 months, said the drug had aided him at the start of his bid to ...

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.